About Prestodiag
Prestodiag is a company based in Villejuif (France) founded in 2012 by Thibaut Mercey. It operates as a B2B. Prestodiag has raised $2.05 million across 1 funding round from investors including CEA Investissement and Karista. Prestodiag operates in a competitive market with competitors including Hygiena, Tangen Biosciences, Aillis, Sanolla and Magnomics, among others.
- Headquarter Villejuif, France
- Founders Thibaut Mercey
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.05 M (USD)
in 1 rounds
-
Latest Funding Round
$2.05 M (USD), Series A
Jun 10, 2014
-
Investors
CEA Investissement
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Prestodiag
Prestodiag has successfully raised a total of $2.05M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.05 million completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prestodiag
Prestodiag has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CEA Investissement and Karista.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in startups are facilitated to valorize CEA technologies.
|
Locked | Locked | Locked | |
|
Karista is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked |
Investor details for Prestodiag
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prestodiag
Investment portfolio details for Prestodiag
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prestodiag
Detailed financials for Prestodiag
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prestodiag Comparisons
Peer comparison for Prestodiag
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prestodiag
Prestodiag operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hygiena, Tangen Biosciences, Aillis, Sanolla and Magnomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of hygiene monitoring systems
|
|
| Locked | Locked | Locked |
Developer of a molecular diagnostics platform
|
|
| Locked | Locked | Locked |
Influenza is diagnosed using an AI-enabled medical device.
|
|
| Locked | Locked | Locked |
AI-based digital diagnostics systems are developed for multiple disease detection.
|
|
| Locked | Locked | Locked |
Provides a portable in-vitro molecular diagnostic device for bacterial detection.
|
Detailed competitors of Prestodiag
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prestodiag
Complete news archive for Prestodiag
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prestodiag
Prestodiag was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Prestodiag is headquartered in Villejuif, France.
Prestodiag is a funded company, having raised a total of $2.05M across 1 funding round to date.
Prestodiag utilizes surface plasmon resonance technology for pathogen detection, focusing on providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and pathogen detection. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Prestodiag's top competitors include Aillis, Hygiena and Definitive Biotechnologies.
Prestodiag has 2 investors. Key investors include CEA Investissement, and Karista.